Wednesday 30 November 2016

Detailed Research on US Dialysis Devices Market 2017 - MedView

US Market Overview for Dialysis Devices 2017 - MedView is a new market research publication announced by Reportstack. The total market comprised the markets for hemodialysis machines, dialysis catheters, dialysis concentrates, dialyzers, dialyzer reprocessing machines, hemodialysis bloodlines, AV fistula needles, AV grafts, AV declotting devices, guidewires, introducer sheaths and water treatment systems. The AV fistula and AV fistula needle market will be the fastest growing market over the forecast perid as the Fistula First Breakthrough Initiative gains more traction and more medical professionals recommend AV fistula’s at hemodialysis initiation for improved results and increased patient safety. The dialysis market, contrary to industry efforts, has been slow to transition away from in-center hemodialysis treatments. The reassurance and safety of having trained professionals available is a strong incentive to follow an in-center treatment plan. Additionally, despite the increasing number of patients requiring dialysis, many are not eligible for home treatment options. The dialysis market is being limited by falling prices and the resistance to transition to home dialysis. While all types of dialysis are still growing, the market share increase per new patient is the lowest for in-center hemodialysis. As more patients shift to alternative methods of treatment, this will help fuel market growth. 
The full report suite on the U.S. market for dialysis includes hemodialysis and peritoneal dialysis machines, dialysis catheters, dialyzers, dialyzer reprocessing machines, hemodialysis bloodline and tubing sets, AV fistula needles, AV access grafts, declotting devices, introducer sheaths and guidewires and water treatment systems. The dialysis patient population has been increasing since 2013 and is projected to continue increasing over the forecast period. Notable trends include shifts between hemodialysis patients and peritoneal dialysis patients as well as the rate of transition from in-center treatment options to personal, home treatment.
Scope
2013-2023
Contact:
Debora White
Manager - Marketing
Ph: +1-888-789-6604
ReportstackMarket Research
###

No comments:

Post a Comment